U-Blot® Research Grade Anti-Human CD47/MER6 (SG404)Cat. No. WA1732Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD47/MER6 (SG404)Cat. No. WA1732
U-Blot® Research Grade Anti-Human CD47/MER6 (sB24M)Cat. No. WA1731
U-Blot® Research Grade Anti-Human CD47/MER6 (RTX-CD47)Cat. No. WA1730
U-Blot® Research Grade Anti-Human CD47/MER6 (NI-1701)Cat. No. WA1729
U-Blot® Research Grade Anti-Human CD47/MER6 (IMM01)Cat. No. WA1728
U-Blot® Research Grade Anti-Human CD47/MER6 (IMC-002)Cat. No. WA1727
U-Blot® Research Grade Anti-Human CD47/MER6 (HMPL-a83)Cat. No. WA1726
U-Blot® Research Grade Anti-Human CD47/MER6 (HMBD-004B)Cat. No. WA1725
U-Blot® Research Grade Anti-Human CD47/MER6 (HMBD-004A)Cat. No. WA1724
U-Blot® Research Grade Anti-Human CD47/MER6 (BAT6004)Cat. No. WA1723
U-Blot® Research Grade Anti-Human CD47/MER6 (AO-176)Cat. No. WA1722
U-Blot® Research Grade Anti-Human CD47/MER6 (ADG 153)Cat. No. WA1721